India Pharma Packaging Market to Grow at 8.7% CAGR by 2034

The pharmaceutical packaging industry plays a pivotal role in safeguarding drug efficacy, ensuring patient safety, and enabling regulatory compliance. As India cements its position as a global pharmaceutical manufacturing hub, packaging technologies are evolving rapidly. According to Expert Market Research, the India pharmaceutical packaging market reached a value of USD 1.73 billion in 2024. The market is projected to expand at a CAGR of 8.70% during 2025-2034, attaining a value of USD 3.98 billion by 2034.

India Pharmaceutical Packaging Market Share

India's pharmaceutical packaging sector is witnessing a shift toward sustainable and patient-centric packaging solutions. The market share is mainly distributed across primary packaging solutions, such as plastic bottles, blister packs, and parenteral containers, due to their direct contact with drugs.

Plastic-based packaging dominates the materials segment, driven by its versatility, lightweight properties, and cost-efficiency. However, glass packaging still retains a significant share, especially in injectables and parenteral drugs, where high chemical resistance is required.

West India, especially Maharashtra and Gujarat, holds the largest regional market share due to the concentration of pharmaceutical manufacturing and contract packaging units. South India follows closely, supported by its robust pharmaceutical R&D infrastructure.

Get a Free Sample Report with Table of Contents - https://bitl.to/4gVq.

India Pharmaceutical Packaging Market Growth & Trends

Key Growth Drivers:

Rising pharmaceutical exports from India to North America, Europe, and Southeast Asia

Stringent regulations on safety and quality, increasing demand for tamper-evident, anti-counterfeit packaging

Technological innovations in drug delivery formats, such as injectables and controlled-release formulations

Increased prevalence of chronic diseases, fueling the demand for packaged medicines

Growth in the e-pharmacy and homecare market requires durable and portable packaging formats

Emerging Trends:

Adoption of smart packaging, including RFID tags and sensors, to track temperature-sensitive biologics

Use of eco-friendly materials such as biodegradable plastics and recyclable paperboard

Rise in unit-dose and patient-specific packaging for better medication adherence

Growing interest in flexible packaging solutions to reduce storage and transportation costs

According to Wikipedia, pharmaceutical packaging encompasses not just the physical materials used to encase drugs, but also labeling, regulatory compliance features, and protective barriers that maintain product integrity.

India Pharmaceutical Packaging Market Case Studies & News

Amcor Plc recently expanded its presence in India with advanced sustainable blister packaging solutions for solid dose medications.

Uflex Ltd. launched an innovative line of multi-layer pharmaceutical laminates to improve barrier properties and extend shelf life.

AptarGroup, Inc. introduced advanced nasal spray devices and closures tailored for India's growing respiratory drug market.

India's PLI (Production Linked Incentive) scheme for pharmaceuticals has prompted new investments in packaging infrastructure by both local and global players.

These developments demonstrate the sector's shift toward quality assurance, technological modernization, and environmental responsibility.

Read the Full Report with the Table of Contents - https://bitl.to/4gVm

India Pharmaceutical Packaging Market Analysis

The market landscape is competitive yet fragmented. Major players include multinational corporations like Gerresheimer AG, WestRock Co., and West Pharmaceutical Services, alongside strong domestic manufacturers such as Uflex Ltd. and SGD S.A. Competitive advantages often depend on compliance with global regulatory standards (FDA, EMA), product innovation, and customization capabilities.

Regulatory Impact:

Compliance with Good Manufacturing Practices (GMP) and Drug Master File (DMF) requirements has increased packaging complexity.

India's Central Drugs Standard Control Organization (CDSCO) mandates strict traceability, pushing companies to adopt serialization and tamper-proof features.

The upcoming EPR (Extended Producer Responsibility) policy is also compelling manufacturers to rethink their packaging sustainability.

India Pharmaceutical Packaging Market Segmentation

By Materials:

Plastics and Polymers

Glass

Paper and Paperboard

Aluminium Foil

Others

By Product Type:

Plastic Bottles

Speciality Bags

Parenteral Containers

Blister Packing

Closures

Labels

Others

By Packaging Type:

Primary

Secondary

Tertiary

By Drug Delivery Mode:

Oral Drugs

Injectable Packaging

Topical

Others

By End Use:

Pharma Manufacturing

Contract Packaging

Retail Pharmacy

Institutional Pharmacy

By Region:

North India

East and Central India

West India

South India

India Pharmaceutical Packaging Market Key Players

Amcor Plc

SGD S.A.

Nipro Corp.

Gerresheimer AG

Uflex Ltd.

West Pharmaceutical Services, Inc.

Sonoco Products Co.

Hoffmann Neopac AG

Schott AG

WestRock Co.

AptarGroup, Inc.

These companies are at the forefront of innovation, sustainability, and regulatory compliance, helping to shape the future of pharmaceutical packaging in India.

Find More Reports

United States Medical Spa Market - https://bitl.to/4c4z

Flow Cytometry Market - https://bitl.to/4dHx

Regenerative Medicine Market - https://bitl.to/4I3l

Pulmonary Arterial Hypertension Market - https://linkd.so/3CrW

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

This release was published on openPR.